AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip Product is used for the occl...
FDA Device Recall #Z-0377-2017 — Class II — September 22, 2016
Recall Summary
| Recall Number | Z-0377-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 22, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | AtriCure, Inc. |
| Location | Mason, OH |
| Product Type | Devices |
| Quantity | 298 |
Product Description
AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip Product is used for the occlusion of the heart's left atrial appendage, under direct visualization, in conjunction with other open cardiac surgical procedures.
Reason for Recall
There is a potential for a component failure of the device which could necessitate medical intervention.
Distribution Pattern
Nationwide Distribution to the follwoing states: AL, AR, AZ, CA, CT, FL, GA, IL, KS, MD, MI, MN, MO, MS, NC, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT & WI. Product was also shipped to the following countries: Poland and Switzerland
Lot / Code Information
Model Numbers: PRO235, PRO240, PRO245 and PRO250 Lot Numbers: 65622 to 66773
Other Recalls from AtriCure, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0927-2024 | Class II | Cryo Module Accessories Domestic CMA-OUS, Pro... | Nov 28, 2023 |
| Z-0928-2024 | Class II | Packaged, Tank Hose Assembly CMA-US, Product Ca... | Nov 28, 2023 |
| Z-1887-2019 | Class II | EPi-Sense Guided Coagulation System with Visitr... | May 29, 2019 |
| Z-0832-2019 | Class II | COBRA FUSION 150 Ablation System (International... | Jan 22, 2019 |
| Z-0831-2019 | Class II | COBRA FUSION 150 Ablation System, Catalog # (RE... | Jan 22, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.